Lionco Pharmaceutical Group Co.,Ltd. (LIONCO PHARMACEUTICAL GROUP CO) aksje
603669.SS
¥4.1200-0.0500 (-1.20%)
Laster graf...
LIONCO PHARMACEUTICAL GROUP CO
Market Cap
$2,934,800,384
Åpning4.1900
Høy4.1900
Lav4.0900
Volum8.13M
P/EN/A
Markedsverdi2.93B
52-ukers høy7.0500
52-ukers lav4.0200
Gj.sn. volum15.29M
UtbytteN/A
BetaN/A
EPS-0.2400
Om Lionco Pharmaceutical Group Co.,Ltd. (LIONCO PHARMACEUTICAL GROUP CO) aksje
Lionco Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products and medical services in China. It offers chemical and prescription drugs for nutrition, antimicrobial, antiviral, digestive, cardiovascular, cerebrovascular, detoxification, anti-tumor, and other applications. The company was founded in 2003 and is based in Shannan, China.
Selskapsinformasjon
Børs: Shanghai (SHH)
Sektor: Sundhed
Industri: Lægemiddelproducenter – Special og generisk
Adresse:
No. 20, National Highway 349
856100 Shannan, China
856100 Shannan, China
Telefon: + 86 89 3783 0666
Nettside: https://www.lingkang.com.cn
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål